Cargando…

Risk factors for developing liver cancer in people with and without liver disease

BACKGROUND: The National Liver Cancer Surveillance Program (NLCSP) targets patients with liver diseases that lead to liver cancer in South Korea. This study aimed to investigate the risk of liver disease leading to liver cancer using nationally representative data to establish an efficient NLCSP. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Jae Kyung, Lee, Jayoun, Lee, Jeong-Hoon, Shin, Sangjin, Tchoe, Ha jin, Kwon, Jin-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205612/
https://www.ncbi.nlm.nih.gov/pubmed/30372481
http://dx.doi.org/10.1371/journal.pone.0206374
_version_ 1783366213407080448
author Suh, Jae Kyung
Lee, Jayoun
Lee, Jeong-Hoon
Shin, Sangjin
Tchoe, Ha jin
Kwon, Jin-Won
author_facet Suh, Jae Kyung
Lee, Jayoun
Lee, Jeong-Hoon
Shin, Sangjin
Tchoe, Ha jin
Kwon, Jin-Won
author_sort Suh, Jae Kyung
collection PubMed
description BACKGROUND: The National Liver Cancer Surveillance Program (NLCSP) targets patients with liver diseases that lead to liver cancer in South Korea. This study aimed to investigate the risk of liver disease leading to liver cancer using nationally representative data to establish an efficient NLCSP. METHODS: This study used data from the National Health Insurance Service National Sample Cohort (NHIS-NSC) from 2002 to 2013. A retrospective matched cohort design was applied to compare the development of liver cancer in patients with and without liver disease. Cox- proportional hazard regression for liver cancer with competing risk of death was performed for all subjects or each group stratified according to age or income level. RESULTS: A total of 66,192 patients with liver disease and matched subjects without liver disease were included in the study. The incidences of liver cancer among patients with and without liver disease within a median 8-year follow-up period were 2.68% (n = 1,772) and 0.34% (n = 210), respectively. Cox- regression analysis for liver cancer incidence indicated that cirrhosis had the highest risk (hazard ratio [HR]: 18.13, 95% confidence interval [CI]: 15.24–21.58), followed by hepatitis B (HR: 9.32, 95% CI: 8.00–10.85). Subgroup analysis showed that the presence of liver disease was an important risk factor in younger as well as elderly people, and a higher risk of liver disease was also observed in the patients with Medicaid. CONCLUSIONS: Attention should be paid to the development of liver cancer in young people under 50 years old and preventive efforts to decrease the incidence of liver cancer among Medicaid recipients is needed.
format Online
Article
Text
id pubmed-6205612
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62056122018-11-19 Risk factors for developing liver cancer in people with and without liver disease Suh, Jae Kyung Lee, Jayoun Lee, Jeong-Hoon Shin, Sangjin Tchoe, Ha jin Kwon, Jin-Won PLoS One Research Article BACKGROUND: The National Liver Cancer Surveillance Program (NLCSP) targets patients with liver diseases that lead to liver cancer in South Korea. This study aimed to investigate the risk of liver disease leading to liver cancer using nationally representative data to establish an efficient NLCSP. METHODS: This study used data from the National Health Insurance Service National Sample Cohort (NHIS-NSC) from 2002 to 2013. A retrospective matched cohort design was applied to compare the development of liver cancer in patients with and without liver disease. Cox- proportional hazard regression for liver cancer with competing risk of death was performed for all subjects or each group stratified according to age or income level. RESULTS: A total of 66,192 patients with liver disease and matched subjects without liver disease were included in the study. The incidences of liver cancer among patients with and without liver disease within a median 8-year follow-up period were 2.68% (n = 1,772) and 0.34% (n = 210), respectively. Cox- regression analysis for liver cancer incidence indicated that cirrhosis had the highest risk (hazard ratio [HR]: 18.13, 95% confidence interval [CI]: 15.24–21.58), followed by hepatitis B (HR: 9.32, 95% CI: 8.00–10.85). Subgroup analysis showed that the presence of liver disease was an important risk factor in younger as well as elderly people, and a higher risk of liver disease was also observed in the patients with Medicaid. CONCLUSIONS: Attention should be paid to the development of liver cancer in young people under 50 years old and preventive efforts to decrease the incidence of liver cancer among Medicaid recipients is needed. Public Library of Science 2018-10-29 /pmc/articles/PMC6205612/ /pubmed/30372481 http://dx.doi.org/10.1371/journal.pone.0206374 Text en © 2018 Suh et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Suh, Jae Kyung
Lee, Jayoun
Lee, Jeong-Hoon
Shin, Sangjin
Tchoe, Ha jin
Kwon, Jin-Won
Risk factors for developing liver cancer in people with and without liver disease
title Risk factors for developing liver cancer in people with and without liver disease
title_full Risk factors for developing liver cancer in people with and without liver disease
title_fullStr Risk factors for developing liver cancer in people with and without liver disease
title_full_unstemmed Risk factors for developing liver cancer in people with and without liver disease
title_short Risk factors for developing liver cancer in people with and without liver disease
title_sort risk factors for developing liver cancer in people with and without liver disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205612/
https://www.ncbi.nlm.nih.gov/pubmed/30372481
http://dx.doi.org/10.1371/journal.pone.0206374
work_keys_str_mv AT suhjaekyung riskfactorsfordevelopinglivercancerinpeoplewithandwithoutliverdisease
AT leejayoun riskfactorsfordevelopinglivercancerinpeoplewithandwithoutliverdisease
AT leejeonghoon riskfactorsfordevelopinglivercancerinpeoplewithandwithoutliverdisease
AT shinsangjin riskfactorsfordevelopinglivercancerinpeoplewithandwithoutliverdisease
AT tchoehajin riskfactorsfordevelopinglivercancerinpeoplewithandwithoutliverdisease
AT kwonjinwon riskfactorsfordevelopinglivercancerinpeoplewithandwithoutliverdisease